E Fund Management (Hong Kong) Co., Ltd.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1777469
CENTRAL, K3
Position in ALNY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$234,201
+$58,510 QoQ
Shares Held
778
+46.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#573
of 784 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026E Fund Management (Hong Kong) Co., Ltd. holds $3,346,723 across 45 Biotechnology names. ALNY ranks #4 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
|
28,209 | $814,675 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,483 | $736,650 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
621 | $387,218 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
778 | $234,201 | |
| 5 | MRNA |
Moderna, Inc.
|
3,249 | $227,527 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
207 | $38,766 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
691 | $37,963 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
128 | $31,330 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $234,201 | 778 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $175,691 | 531 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $154,685 | 389 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||